Skip to content
Medical Health Aged Care, Sport Recreation

Supercars legend Allan Moffat drives focus on dementia at Penrite Oil Sandown 500

Dementia Australia 3 mins read

Dementia Australia is thrilled to be back for a second year as the nominated charity for the Penrite Oil Sandown 500, one of the greatly anticipated races returning to the Repco Supercars Championships calendar. 

 

Supercars, Penrite Racing and Penrite Oil, the major sponsor and partner of the Supercars event, nominated Dementia Australia as their charity partner as a tribute to Dementia Australia Patron, Allan Moffat OBE, Supercars Legend, Hall of Fame inductee, and four-time Bathurst 1000 winner who is living with Alzheimer’s disease.

 

Dementia Australia CEO Professor Tanya Buchanan said it was a privilege to be part of such a significant event in the Repco Supercars Championships calendar.

 

“Thank you to Penrite Oil, Penrite Racing, Supercars and most importantly to Allan Moffat and his network of supporters for continuing to give back to the racing community and helping all racegoers to know that if they are impacted by dementia – they are not alone,” Professor Buchanan said.

 

“I also thank Steve Grove of Grove Racing who partners with Penrite for his support and generous donation to Dementia Australia in honour of a close family member. The Grove family like so many Australians, has been impacted by dementia.

 

“Allan Moffat as our Dementia Australia Patron and his support network have been so generous in sharing  his diagnosis and experience of living with Alzheimer’s disease to raise awareness in the community and vital funds for Dementia Australia at fundraising.dementia.org.au/allan-moffat.

 

“Allan first talked about his diagnosis of Alzheimer’s disease in September 2019 and with his support network he has continued to raise awareness about dementia as a Dementia Australia Patron.”

 

Jarrod Harding, Brand Manager Penrite Oil said: “We are so pleased to be working again with Allan Moffat and Dementia Australia.

 

“It’s a privilege to be able to show our support for Allan, one of my heroes, and for Dementia Australia” Mr Harding said.

 

“With more than 421,000 Australians estimated to be living with dementia and more than 1.6 million people involved in their care, it's an important cause for everyone and especially close to our hearts here at Penrite Oil.

 

“As an Australian family-owned business with strong community values, we feel it's important to give back and support those who need it most.

 

“As part of the partnership, Penrite Oil will be working with Allan Moffat and his support team to promote Dementia Australia's work and to encourage community support for the charity's activities.

 

“It’s exciting this year as racing enthusiasts at the event will be treated to seeing a tribute of the 1974 Ford XB Brut 33 Falcon on the 50-year anniversary of Allan’s win at Sandown.”

 

The three-day race event is from Friday 13 to Sunday 15 September at the Sandown International Motor Raceway, Melbourne and across the event racegoers and broadcast audiences will see Dementia Australia’s logo included in the historic livery on Penrite Racing’s Ford Mustangs. 

 

Penrite Oil Sandown 500 racegoers are encouraged to visit Dementia Australia’s marquee on site across the three event days where there will be information, and they can purchase merchandise and commemorative Allan Moffat OBE pins. 

 

“The Penrite Oil Sandown 500 is the perfect lead into Dementia Australia Action Week which will run from 16-22 September,” Professor Buchanan said.

 

“Head to dementia.org.au to find out how you can join us to create a future where all people impacted by dementia are supported and welcomed in their communities, no matter where they live.

 

“I encourage anyone who has concerns about themselves or someone close to them to contact the National Dementia Helpline on 1800 100 500. It’s available for free, 24 hours a day, seven days a week, 365 days a year.”

 

 

-Ends-

 

 

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Gabrielle Prabhu, Media & Communications Manager, 0447 253 583 or Gabrielle.Prabhu@dementia.org.au

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

More from this category

  • General News, Medical Health Aged Care
  • 19/09/2024
  • 07:59
Monash Uinversity

New study: Risky sleeping pill use reduced through self-guided interventions

An international team of multidisciplinary researchers led by Canada’s Dalhousie University in collaboration with Monash University have developed a simple and scalable direct-to-patient intervention…

  • Contains:
  • Medical Health Aged Care, Women
  • 19/09/2024
  • 06:51
Jean Hailes for Women's Health

Jean Hailes welcomes Senate Inquiry report on perimenopause and menopause

Jean Hailes for Women's Health welcomes the tabling of the landmark report from the Senate Inquiry into issues related to menopause and perimenopause, commending the attention being given to issues that affect millions of Australian women. Dr. Sarah White, CEO of Jean Hailes, said the report highlights critical areas to improve support and health care for women during and after the menopause transition. “We are particularly pleased to see recommendations for improved healthcare professional education, affordable treatments and workplace flexibility." “Jean Hailes strongly supports the recommendations for improved menopause education in medical training and public awareness campaigns to reduce stigma.…

  • Medical Health Aged Care
  • 18/09/2024
  • 21:41
Organon & Co.

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.